tiprankstipranks
Advertisement
Advertisement
Avenue Therapeutics Sells Baergic Bio to Axsome
PremiumCompany AnnouncementsAvenue Therapeutics Sells Baergic Bio to Axsome
5M ago
Avenue Therapeutics announces Baergic Bio acquisition by Axsome
Premium
The Fly
Avenue Therapeutics announces Baergic Bio acquisition by Axsome
5M ago
Axsome enters agreement to obtain exclusive global rights to AZD7325
Premium
The Fly
Axsome enters agreement to obtain exclusive global rights to AZD7325
5M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1y ago
Avenue Therapeutics files $35M mixed securities shelf
Premium
The Fly
Avenue Therapeutics files $35M mixed securities shelf
1y ago
Avenue Therapeutics reports Q3 EPS  $(1.92) , consensus (94c)
Premium
The Fly
Avenue Therapeutics reports Q3 EPS $(1.92) , consensus (94c)
1y ago
Avenue Therapeutics reports Q1 EPS ($15.40) vs ($101.57) last year
PremiumThe FlyAvenue Therapeutics reports Q1 EPS ($15.40) vs ($101.57) last year
2y ago
Avenue Therapeutics files to sell 1.42M shares of common stock for holders
Premium
The Fly
Avenue Therapeutics files to sell 1.42M shares of common stock for holders
2y ago
Avenue Therapeutics trading resumes
Premium
The Fly
Avenue Therapeutics trading resumes
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100